Lower riskDrug recall · FDA · Published April 24, 2020
Harvard Drug Group Memantine Capsules Recall: Failed Dissolution Testing
Harvard Drug Group recalls 28mg Memantine Hydrochloride Extended-Release Capsules due to failed dissolution testing in stability checks. This affects Rx-only products with specific NDC and lot numbers.
“Harvard Drug Group Memantine Capsules Recall: Failed Dissolution Testing.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37132-harvard-drug-group-memantine-capsules-recall-failed-dissolution-testing. Based on FDA recall #D-1262-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1262-2020%22&limit=1).
The Food and Drug Administration announced on April 24, 2020, that The Harvard Drug Group voluntarily recalled Memantine Hydrochloride Extended-Release Capsules due to failed dissolution specifications. The recall involves 678 cartons distributed in Alabama, Florida, Iowa, New York, Ohio, and Texas.
The recall was initiated because the product failed dissolution specifications, with low stage 3 results obtained during routine stability testing. The FDA classified this as a Class III recall.
Context
GovInfoNow's records show The Harvard Drug Group has 20 other recalls on record since July 15, 2016. Other recent recalls of similar products include Harvard Drug Group Recalls Tramadol Tablets Due to Packaging Defect (June 16, 2023) and Harvard Drug Group Recalls Gabapentin Tablets Due to Foreign Tablet Mixup (April 24, 2023). Additional context includes the Sun Pharmaceutical Lisdexamfetamine Capsules Recall regarding failed dissolution tests on October 28, 2025.
How to tell if you have this one
Check for NDC number 0904-6735-61 and lot numbers M02199D or M02246D with expiration date 5/2020. The product is prescription-only and sold in 100-capsule cartons.
Brand
The Harvard Drug Group
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Verify the NDC number 0904-6735-61 and lot numbers M02199D or M02246D with expiration date 5/2020.
Where it went and when
Where it was distributed
Distributed in 6 states.
Listed by the agency
Not listed
FDA distribution: “AL, FL, IA, NY, OH, TX” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Alabama, Florida, Iowa, New York, Ohio, Texas.
Recall timeline
FDA terminated this recall 2.3 years after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1262-2020 (April 24, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1262-2020 to see it in context.
Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.